Shell Asset Management’s Moderna MRNA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13K | Sell |
464
-531
| -53% | -$14.9K | ﹤0.01% | 1245 |
|
2025
Q1 | $28K | Hold |
995
| – | – | ﹤0.01% | 1211 |
|
2024
Q4 | $41K | Hold |
995
| – | – | ﹤0.01% | 1197 |
|
2024
Q3 | $66K | Buy |
+995
| New | +$66K | ﹤0.01% | 1140 |
|
2024
Q1 | $118K | Sell |
995
-694
| -41% | -$82.3K | 0.01% | 976 |
|
2023
Q4 | $168K | Sell |
1,689
-4,160
| -71% | -$414K | 0.01% | 914 |
|
2023
Q3 | $604K | Buy |
5,849
+71
| +1% | +$7.33K | 0.03% | 488 |
|
2023
Q2 | $702K | Sell |
5,778
-2,973
| -34% | -$361K | 0.03% | 463 |
|
2023
Q1 | $1.34M | Sell |
8,751
-41
| -0.5% | -$6.3K | 0.06% | 317 |
|
2022
Q4 | $1.58M | Sell |
8,792
-3,433
| -28% | -$617K | 0.07% | 282 |
|
2022
Q3 | $1.45M | Sell |
12,225
-2,873
| -19% | -$340K | 0.06% | 309 |
|
2022
Q2 | $2.16M | Buy |
15,098
+831
| +6% | +$119K | 0.06% | 292 |
|
2022
Q1 | $2.46M | Buy |
14,267
+45
| +0.3% | +$7.75K | 0.06% | 299 |
|
2021
Q4 | $3.61M | Buy |
14,222
+128
| +0.9% | +$32.5K | 0.07% | 249 |
|
2021
Q3 | $5.42M | Buy |
14,094
+228
| +2% | +$87.7K | 0.12% | 183 |
|
2021
Q2 | $3.26M | Buy |
13,866
+6,803
| +96% | +$1.6M | 0.06% | 279 |
|
2021
Q1 | $925K | Buy |
7,063
+318
| +5% | +$41.6K | 0.02% | 565 |
|
2020
Q4 | $705K | Buy |
6,745
+5,175
| +330% | +$541K | 0.01% | 629 |
|
2020
Q3 | $111K | Hold |
1,570
| – | – | ﹤0.01% | 1150 |
|
2020
Q2 | $101K | Buy |
+1,570
| New | +$101K | ﹤0.01% | 1146 |
|